1/ ⏰ for #EBGI Tweetorial🧵 w/@montalvan214 “Hot Take: Can We Lengthen Surveillance Intervals After EMR With Margin Thermal Ablation?” 📜Summary shorturl.at/otY1N 🎧 shorturl.at/Kxg7j 📰 shorturl.at/grtN2 #GITwitter

Join us for #EBGIvsCRC during Patient Empowerment Week! 🩺 💙Romy Chamoun, MD is educating us on the #ClearLiquidDiet. Big thanks to @montalvan214 for the stellar video editing! ⭐️ #PatientEmpowerment #CRCawareness

1/ As part of Week 3 of our #CRCAwarenessMonth campaign, we present our second of two ”Q&A with an Expert” sessions on non-modifiable CRC risk! ⭐️Risk of CRC in Patients with IBD⭐️ with the one and only @Dr. Samir A Shah ( & moderator Hannah W Fiske Goodrich, MD ) 🧠 Scroll to learn more 👇🏽

🔵#ColonCancerAwarnessMonth🔵 Tomorrow -Join Us- Evidence-Based GI: An ACG Publication (EBGI) & #ScopingSundays collaboration 🔥🔥 The topic near & dear to every #GI’s 💙-“From Screening to Resection: Advancing CRC Prevention” Moderated by Umer Farooq & Romy Chamoun, MD -& our Expert Guest Mohammad Bilal, MD

🚨SPECIAL ANNOUNCEMENT🚨 In light of ✨Colorectal Cancer Awareness Month✨, EBGI is proud to present: 💙🩵Surviving Colon Cancer🩵💙 Featuring: 🌟Dr. Clive Miranda - EBGI Ambassador 🌟Dr. Amanda Duggan - Colon Cancer Survivor Watch the exclusive interview 🧵 below👇🏻

An enlightening #ScopingSundays and Evidence-Based GI: An ACG Publication (EBGI) session on Colon Cancer Prevention by the great Mohammad Bilal, MD, Umer Farooq and Romy Chamoun, MD 🔥

The Difficult Colonoscopy is humbling to all endoscopists. My Pearls : #1 Female Patients If hysterectomy or diverticulitis, use pedi colonoscope + water immersion. (Angulated colon) If chronic idiopathic constipation or visceral obese, use adult colonoscope (redundant colon)

Applying for #GIFellowship is both exciting & nerve wracking😳 Its ⏰ to get ready 🙌 Hear from PDs & #GIFellows ✅Application pearls ✅LORs ✅PS ✅Interviews Who should attend? 🎯Prospective applicants 🎯If you mentor residents 👉 register.gotowebinar.com/register/29401…

New ACG Guideline Alert! Gastric cancer rates in the U.S. are 2-13x higher in certain non-White & immigrant populations — yet most cases are caught too late. The latest ACG guideline focuses on managing gastric premalignant conditions to change that. Early

Applying to #GIfellowship? Join us! GI & Hepatology Fellowship Match Application Wednesday, April 16 @ 8 pm ET 🔑 Components of a successful application 🕳️ Common pitfalls to avoid 🌟 Strategies to enhance your candidacy Register ➡️ gi.org/ACGVGR

1/ ⏰ for #EBGI Tweetorial🧵w/ Aastha Chokshi, MD! “Decreasing Cirrhosis Risk in MASLD: Don’t Drink Alcohol!” 📜Summary: shorturl.at/Be3iX 🎧shorturl.at/uhWEa 📰 shorturl.at/q0Of1 #GITwitter

Algorithm for Chronic Diarrhea ▪️Blood, fat, pain or malabsorption? ▪️CBC, CMP, ESR, CRP, tTG, C4, Fe, FCP ▪️Follow findings from limited work-up ▪️Focus of stool testing ▪️Trial of anti-diarrheal and titrate up 🔗 pubmed.ncbi.nlm.nih.gov/39480027/ 🙏 Michael Camilleri, MACG

Management of incidentally found gallbladder polyps - Recommendations of the Society of Radiologissts in Ultrasound (SRU)

In #EBGI: Bridging the Gap: Impact of Gender-Affirming Care on IBD Flare Rates Hayley Rogers, MD & Nikki Duong, MD   📖 bit.ly/44OI4Pq 📕doi.org/10.14309/ajg.0… Hayley Rogers Nikki Duong, M.D. Kira Newman, MD, PhD Ben Click Sara Horst MD, MPH, FACG Victor Chedid, MD Paul Kwo

Early year PSAs #2 for #GI fellows: 🟢Use professional language to talk about colorectal surgeries (👇) 🟢🔑 differences = rectum gone (bottom 3) = ostomy. 🟢 Location of #IBD dictates surgical approach, understand this, and CRS will like you.

🚨 Attention 1️⃣st year GI fellows 🚨 Enjoying your first few weeks of fellowship? Still struggling to find your feet? 😬 🌟 Check out our GI Fellow Handbook 📖 💡 A nifty guide for tips, tricks, and advice for those formulative early months ✅ ✍️ BY 1st years ✍️ FOR 1st years

First time reaching the cecum today! #chroniclesofanewGIFellow 💩💩💩💩💩

♥️ Thank you ACG for highlighting our article in the #ACGMagazine on interviewing for the GI #FellowshipMatch ✨ Great work from the team 👏 Mad proud! #GITwitter #MedTwitter #FutureOfGI

🚨BREAKING: FDA grants accelerated approval to Wegovy (semaglutide 2.4 mg injection) for treating adults with non‑cirrhotic metabolic dysfunction‑associated steatohepatitis (MASH) with moderate to advanced liver fibrosis - - - A Fourth Indication for Wegovy Wegovy’s FDA-approved

This is THE place to learn about applying to GI as a Hepato-curious resident. From considering fast-track vs. traditional 4th year Hepatology Fellowships to considerations for IMG applicants, this webinar will have it all! A do not miss!